Efficacy of a novel chewable tablet (Credelio Quattro<sup>™</sup>) containing lotilaner, moxidectin, praziquantel, and pyrantel for the treatment and control of Echinococcus multilocularis and E. granulosus infections in dogs. [PDF]
Charles S +8 more
europepmc +1 more source
The grey wolf (Canis lupus) as a host of Echinococcus multilocularis, E. granulosus s.l. and other helminths - a new zoonotic threat in Poland. [PDF]
Karamon J +6 more
europepmc +1 more source
Corrigendum to "Detection of Asian genetic components in autochthonous human <i>Echinococcus multilocularis</i> infections from endemic Warmia-Masuria (north-eastern Poland)" [One Health, volume 17, article number 100623]. [PDF]
Gładysz P, Lass A.
europepmc +1 more source
Association between HLA-DR13 and Susceptibility to Alveolar Echinococcosis [PDF]
Bettens, Florence, Gottstein, Bruno
core
Efficacy and Safety of Asparagusic Acid against Echinococcus multilocularis In Vitro and in a Murine Infection Model. [PDF]
Lu Z, Wang Y, Liu C, Fan H.
europepmc +1 more source
Current status and future prospects of Echinococcus multilocularis vaccine candidates: A systematic review. [PDF]
Hataminejad M +8 more
europepmc +1 more source
Ubenimex combined with Albendazole for the treatment of Echinococcus multilocularis-induced alveolar echinococcosis in mice. [PDF]
Zhou Z, Huayu M, Mu Y, Tang F, Ge RL.
europepmc +1 more source
Related searches:
Intraocular Echinococcus multilocularis
Archives of Ophthalmology, 1987Alveolar hydatid disease, caused by the organism Echinococcus multilocularis, is a potentially lethal helminthic infection. After initial hepatic infestation, the organism may spread locally and hematogenously to distant sites. Death occurs secondary to hepatic failure, local extension into vital structures, or metastasis to the brain or lungs.
D F, Williams +4 more
openaire +2 more sources

